Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX^®-Design Nanoparticles

• Egile Nagusiak: Lucie Lerouge (Egilea), Mickaël Gries (Egilea), Alicia Chateau (Egilea), Joël Daouk (Egilea), François Lux (Egilea), Paul Rocchi (Egilea), Jessica Cedervall (Egilea), Anna-Karin Olsson (Egilea), Olivier Tillement (Egilea), Céline Frochot (Egilea), Samir Acherar (Egilea), Noémie Thomas (Egilea), Muriel Barberi-Heyob (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Glioblastoma (GBM) is the most difficult brain cancer to treat, and photodynamic therapy (PDT) is emerging as a complementary approach to improve tumor eradication. Neuropilin-1 (NRP-1) protein expression plays a critical role in GBM progression and immune response. Moreover, various clinical databa...